Effects of the COVID-19 pandemic on surgical treatment for thoracic malignant tumor cases in Japan: a national clinical database analysis
Surgery Today · 2025
DOI: 10.1007/s00595-024-02907-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery Today, 2025. Verfasst von Yasushi Shintani und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, 2-2-L5, Yamadaoka, Suita, Osaka, 565-0871, Japan. yshintani@tho…. Hauptthemen laut MEDLINE: COVID-19, Lung Neoplasms, Mediastinal Neoplasms, Pandemics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MHLW Research Program on Emerging and Reemerging Infectious Diseases, Osaka University.
Abstract (Originalsprache)
Objective
Surgical care has been significantly affected by the COVID-19 pandemic. This study was conducted to evaluate the effects of the pandemic on lung cancer and mediastinal tumor surgery.
Methods
Changes in the number of surgical procedures for lung cancer and mediastinal tumors were analyzed using the National Clinical Database of Japan. Patient characteristics, including disease stage and histological type, from 2019 to 2022 were evaluated using annual datasets.
Results
Comparisons with 2019 showed that the number of patients who underwent surgery for primary lung cancer or a mediastinal tumor decreased in 2020 and then remained stable. There were no clinically significant changes in the trend over the four-year period regarding the number of patients for each clinical and pathological stage of lung cancer. Regarding mediastinal tumors, there was no significant difference in tumor size between years. There was a slight change in the selection of surgical indication during the second quarter of 2020, although its impact on annual trends in the stage distribution for lung cancer and primary disease for mediastinal tumors was minimal.
Conclusions
Analyses of lung cancer and mediastinal tumor surgery cases in Japan during the COVID-19 pandemic showed no significant disease profile changes related to treatment delay.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, 2-2-L5, Yamadaoka, Suita, Osaka, 565-0871, Japan. yshintani@thoracic.med.osaka-u.ac.jp.
- Department of Healthcare Quality Assessment, The University of Tokyo, Tokyo, Japan.
- Department of Thoracic Surgery, University of Tsukuba, Ibaraki, Japan.
- Division of Thoracic Surgery, Department Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Division of Thoracic Surgery, Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
- Department of Thoracic Surgery, Kanagawa Cancer Center, Kanagawa, Japan.
Förderung
- MHLW Research Program on Emerging and Reemerging Infectious Diseases
- Osaka University
Zitieren
APA
Shintani, Y., Yamamoto, H., Sato, Y., Inoue, M., Asakura, K., Ito, H., Uramoto, H., Okada, Y., Sato, T., Fukui, M., Hoshikawa, Y., Chen-Yoshikawa, T. F., Chida, M., Ikeda, N., & Yoshino, I. (2025). Effects of the COVID-19 pandemic on surgical treatment for thoracic malignant tumor cases in Japan: a national clinical database analysis. Surgery Today. https://doi.org/10.1007/s00595-024-02907-w
Vancouver
Shintani Y, Yamamoto H, Sato Y, Inoue M, Asakura K, Ito H, et al. Effects of the COVID-19 pandemic on surgical treatment for thoracic malignant tumor cases in Japan: a national clinical database analysis. Surgery Today. 2025. doi:10.1007/s00595-024-02907-w
BibTeX
@article{Shintani2025,
author = {Shintani, Yasushi and Yamamoto, Hiroyuki and Sato, Yukio and Inoue, Masayoshi and Asakura, Keisuke and Ito, Hiroyuki and Uramoto, Hidetaka and Okada, Yoshinori and Sato, Toshihiko and Fukui, Mariko and Hoshikawa, Yasushi and Chen-Yoshikawa, Toyofumi Fengshi and Chida, Masayuki and Ikeda, Norihiko and Yoshino, Ichiro},
title = {Effects of the COVID-19 pandemic on surgical treatment for thoracic malignant tumor cases in Japan: a national clinical database analysis},
journal = {Surgery Today},
year = {2025},
doi = {10.1007/s00595-024-02907-w}
}
EUVIMED